(R,R)-1,2-Bis(Methanesulphonyloxymethyl)cyclohexane, 95.0%, 5g

Lactic acid, 80%, of which at least 95% L(+)-lactic acid, 1 l, plastic packaging.

Piperazine-1-carboxamidine hemisulfate, 95.0%, 250mg

ETHYL 3-OXOBICYCLO[3.1.0]HEXANE-6-CARBOXYLATE, 95.0%, 250mg

1-(2,4-dichlorobenzoyl)-2-methylpiperazine, 95.0%, 1g

2-Hydroxy-5-iodonicotinic acid, 97.0%, 10g

tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}azetidine-1-carboxylate, 97.0%, 10g

Methyl 1H-pyrrolo[3,2-c]pyridine-4-carboxylate, 95.0%, 10g

7-METHOXYISOQUINOLIN-1(2H)-ONE, 95%, 500mg

D-Glucamine>97.0%(T)25g

1-Isopropylpiperidine-2,4-dione, 98%, 250mg

Sofosbuvir impurity H, 1mg

[S(R)]-N-[(1S)-2-(Diphenylphosphino)-1-[2-(diphenylphosphino)phenyl]ethyl]]-2-methyl-N,2-dimethyl-2-propanesulfinamide, 95%, 250mg